Table of Contents Table of Contents
Previous Page  658-659 / 1726 Next Page
Information
Show Menu
Previous Page 658-659 / 1726 Next Page
Page Background

Pooled randomised NSGO-EORTC/Iliade trials

Radiotherapy vs RT plus platinum-based chemotherapy x4

Progression free survival

Overall survival

Hogberg et al, EJC 2010

PFS 69 vs 78%, p=0.009

OS 75 vs 82%, p=0.07

Serous and clear cell cancers in

NSGO/EORTC trial (33%)